Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Current Assets: 2015-2019

Historic Current Assets for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $13.5 million.

  • Outlook Therapeutics' Current Assets rose 50.11% to $28.2 million in Q2 2020 from the same period last year, while for Jun 2020 it was $28.2 million, marking a year-over-year increase of 50.11%. This contributed to the annual value of $13.5 million for FY2019, which is 308.83% up from last year.
  • Per Outlook Therapeutics' latest filing, its Current Assets stood at $13.5 million for FY2019, which was up 308.83% from $3.3 million recorded in FY2018.
  • Outlook Therapeutics' 5-year Current Assets high stood at $15.2 million for FY2015, and its period low was $3.3 million during FY2018.
  • Its 3-year average for Current Assets is $6.9 million, with a median of $3.9 million in 2017.
  • Its Current Assets has fluctuated over the past 5 years, first crashed by 62.55% in 2016, then soared by 308.83% in 2019.
  • Over the past 5 years, Outlook Therapeutics' Current Assets (Yearly) stood at $15.2 million in 2015, then plummeted by 62.55% to $5.7 million in 2016, then plummeted by 31.24% to $3.9 million in 2017, then decreased by 15.42% to $3.3 million in 2018, then spiked by 308.83% to $13.5 million in 2019.